• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Fighting the pandemic with collaboration at heart: Report from cardiologists in a COVID-19-dedicated Portuguese intensive care unit.齐心抗疫:来自 COVID-19 专用葡萄牙重症监护病房心脏病专家的报告。
Rev Port Cardiol (Engl Ed). 2021 Dec;40(12):923-928. doi: 10.1016/j.repce.2021.11.009.
2
Fighting the pandemic with collaboration at heart: Report from cardiologists in a COVID-19-dedicated Portuguese intensive care unit.以合作之心抗击疫情:来自葡萄牙一家新冠肺炎专用重症监护病房心脏病专家的报告
Rev Port Cardiol. 2021 Dec;40(12):923-928. doi: 10.1016/j.repc.2021.01.011. Epub 2021 Aug 20.
3
Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy.重症监护治疗新型冠状病毒 SARS-CoV-2 感染患者:意大利克雷马医院的经验。
Am J Emerg Med. 2021 Jul;45:156-161. doi: 10.1016/j.ajem.2020.08.005. Epub 2020 Aug 16.
4
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.意大利伦巴第地区 1591 名 ICU 收治的 SARS-CoV-2 感染患者的基线特征和结局。
JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394.
5
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
6
Characteristics and outcome of critically ill patients with coronavirus disease-2019 (COVID-19) pneumonia admitted to a tertiary care center in the United Arab Emirates during the first wave of the SARS-CoV-2 pandemic. A retrospective analysis.在 2019 年冠状病毒病(COVID-19)肺炎危重症患者的特征和结局中,阿联酋一家三级保健中心在 SARS-CoV-2 大流行的第一波期间收治的患者。一项回顾性分析。
PLoS One. 2021 Oct 22;16(10):e0251687. doi: 10.1371/journal.pone.0251687. eCollection 2021.
7
Characteristics and outcomes of patients with COVID-19 admitted to hospital and intensive care in the first phase of the pandemic in Canada: a national cohort study.加拿大疫情第一阶段住院和重症监护的 COVID-19 患者的特征和结局:一项全国性队列研究。
CMAJ Open. 2021 Mar 8;9(1):E181-E188. doi: 10.9778/cmajo.20200250. Print 2021 Jan-Mar.
8
SARS-CoV-2 in Spanish Intensive Care Units: Early experience with 15-day survival in Vitoria.西班牙重症监护病房中的 SARS-CoV-2:维多利亚 15 天生存的早期经验。
Anaesth Crit Care Pain Med. 2020 Oct;39(5):553-561. doi: 10.1016/j.accpm.2020.04.001. Epub 2020 Apr 9.
9
Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.意大利伦巴第地区重症监护病房中 COVID-19 患者死亡的相关危险因素。
JAMA Intern Med. 2020 Oct 1;180(10):1345-1355. doi: 10.1001/jamainternmed.2020.3539.
10
Acute Cardiovascular Manifestations in 286 Children With Multisystem Inflammatory Syndrome Associated With COVID-19 Infection in Europe.欧洲 286 例 COVID-19 感染相关儿童多系统炎症综合征的急性心血管表现。
Circulation. 2021 Jan 5;143(1):21-32. doi: 10.1161/CIRCULATIONAHA.120.050065. Epub 2020 Nov 9.

引用本文的文献

1
Relation of COVID-19 with liver diseases and their impact on healthcare systems: The Portuguese case.新冠病毒感染与肝脏疾病的关系及其对医疗保健系统的影响:葡萄牙案例。
World J Gastroenterol. 2023 Feb 14;29(6):1109-1122. doi: 10.3748/wjg.v29.i6.1109.
2
Clinical Characteristics and Mortality-Associated Factors in COVID-19 Critical Patients in a Portuguese ICU.葡萄牙一家重症监护病房中新冠肺炎危重症患者的临床特征及死亡相关因素
Cureus. 2022 Sep 26;14(9):e29610. doi: 10.7759/cureus.29610. eCollection 2022 Sep.
3
Temporary mechanical circulatory support for COVID-19 patients: A systematic review of literature.COVID-19 患者的临时机械循环支持:文献系统评价。
Artif Organs. 2022 Jul;46(7):1249-1267. doi: 10.1111/aor.14261. Epub 2022 May 1.
4
A fresh future forged in fear and failure.在恐惧与失败中铸就的崭新未来。
Rev Port Cardiol (Engl Ed). 2021 Dec;40(12):929-931. doi: 10.1016/j.repce.2021.11.010.
5
A fresh future forged in fear and failure.在恐惧与失败中铸就的崭新未来。
Rev Port Cardiol. 2021 Dec;40(12):929-931. doi: 10.1016/j.repc.2021.09.009. Epub 2021 Oct 27.

本文引用的文献

1
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19.羟氯喹或联合阿奇霉素治疗轻中度 COVID-19。
N Engl J Med. 2020 Nov 19;383(21):2041-2052. doi: 10.1056/NEJMoa2019014. Epub 2020 Jul 23.
2
Takotsubo cardiomyopathy triggered by SARS-CoV-2 infection in a critically ill patient.一名危重症患者中由新型冠状病毒2型(SARS-CoV-2)感染引发的应激性心肌病。
BMJ Case Rep. 2020 Jun 14;13(6):e236561. doi: 10.1136/bcr-2020-236561.
3
Takotsubo Syndrome in the Setting of COVID-19.新冠肺炎背景下的应激性心肌病
JACC Case Rep. 2020 Jul 15;2(9):1321-1325. doi: 10.1016/j.jaccas.2020.04.023. Epub 2020 May 1.
4
Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19.肾素-血管紧张素-醛固酮系统抑制剂与新冠病毒风险。
N Engl J Med. 2020 Jun 18;382(25):2441-2448. doi: 10.1056/NEJMoa2008975. Epub 2020 May 1.
5
Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19.肾素-血管紧张素-醛固酮系统阻滞剂与新冠病毒风险。
N Engl J Med. 2020 Jun 18;382(25):2431-2440. doi: 10.1056/NEJMoa2006923. Epub 2020 May 1.
6
Clinical Characteristics of Covid-19 in New York City.纽约市新冠肺炎的临床特征
N Engl J Med. 2020 Jun 11;382(24):2372-2374. doi: 10.1056/NEJMc2010419. Epub 2020 Apr 17.
7
Myocardial localization of coronavirus in COVID-19 cardiogenic shock.COVID-19 心原性休克中冠状病毒的心肌定位。
Eur J Heart Fail. 2020 May;22(5):911-915. doi: 10.1002/ejhf.1828. Epub 2020 Apr 11.
8
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.意大利伦巴第地区 1591 名 ICU 收治的 SARS-CoV-2 感染患者的基线特征和结局。
JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394.
9
Critically ill patients with COVID-19 in Hong Kong: a multicentre retrospective observational cohort study.香港新冠肺炎危重症患者:一项多中心回顾性观察队列研究。
Crit Care Resusc. 2020 Apr 6;22(2):119-125. doi: 10.51893/2020.2.oa1.
10
Cardiovascular disease and COVID-19.心血管疾病与新型冠状病毒肺炎
Diabetes Metab Syndr. 2020 May-Jun;14(3):247-250. doi: 10.1016/j.dsx.2020.03.013. Epub 2020 Mar 25.

齐心抗疫:来自 COVID-19 专用葡萄牙重症监护病房心脏病专家的报告。

Fighting the pandemic with collaboration at heart: Report from cardiologists in a COVID-19-dedicated Portuguese intensive care unit.

机构信息

Centro Hospitalar de Vila Nova de Gaia/Espinho, Cardiology Department, Vila Nova de Gaia, Portugal.

Centro Hospitalar de Vila Nova de Gaia/Espinho, Cardiology Department, Vila Nova de Gaia, Portugal.

出版信息

Rev Port Cardiol (Engl Ed). 2021 Dec;40(12):923-928. doi: 10.1016/j.repce.2021.11.009.

DOI:10.1016/j.repce.2021.11.009
PMID:34922698
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8673477/
Abstract

INTRODUCTION AND OBJECTIVES

The coronavirus disease 2019 (COVID-19) spread quickly around the world. Although mainly a respiratory illness, there is growing interest in non-respiratory manifestations, particularly cardiovascular ones. At our center, mobilization of cardiologists with intensive care training was needed. Our aim is to describe patients with severe COVID-19 admitted to a Portuguese intensive care unit (ICU), the cardiovascular impact of the disease and the experience of cardiologists working in a COVID-19 ICU.

METHODS

Data from adult patients with COVID-19 admitted to the ICU of Centro Hospitalar de Vila Nova de Gaia/Espinho between 16 March 2020 and 21 April 2020 were analyzed retrospectively.

RESULTS

Thirty-five patients were admitted. Mean age was 62.6±6.0 years and 23 (65.7%) were male. Dyslipidemia was the most common cardiovascular risk factor (65.7%, n=23), followed by hypertension (57.1%, n=20). Mean ICU stay time was 15.9±10.0 days. Patients had high rates of mechanical ventilation (88.6%, n=31) and vasopressor support (88.6%, n=31). Low rates of new onset left systolic dysfunction were detected (8.5%, n=2). One patient required venoarterial extra-corporeal membrane oxygenation. Mortality was 25% (n=9). Acute myocardial injury and N-terminal pro-B-type natriuretic peptide (NT-proBNP) elevation was detected in 62.9% (n=22). Patients that died had higher NT-proBNP compared to those discharged alive (p<0.05). Care by cardiologists frequently changed decision making.

CONCLUSIONS

The cardiovascular impact of COVID-19 seems relevant but is still widely unknown. Studies are needed to clarify the role of cardiac markers in COVID-19 prognosis. Multidisciplinary care most likely results in improved patient care.

摘要

简介与目的

2019 年冠状病毒病(COVID-19)在全球迅速传播。虽然它主要是一种呼吸道疾病,但人们对非呼吸道表现,特别是心血管表现的兴趣日益增加。在我们中心,需要动员有重症监护培训的心脏病专家。我们的目的是描述入住葡萄牙重症监护病房(ICU)的严重 COVID-19 患者、该疾病对心血管的影响以及在 COVID-19 ICU 工作的心脏病专家的经验。

方法

回顾性分析 2020 年 3 月 16 日至 4 月 21 日期间入住 Vila Nova de Gaia/Espinho 中心医院 ICU 的 COVID-19 成年患者的数据。

结果

共收治 35 例患者。平均年龄为 62.6±6.0 岁,23 例(65.7%)为男性。血脂异常是最常见的心血管危险因素(65.7%,n=23),其次是高血压(57.1%,n=20)。平均 ICU 住院时间为 15.9±10.0 天。患者机械通气(88.6%,n=31)和血管加压素支持(88.6%,n=31)的比例较高。新发左室收缩功能障碍的发生率较低(8.5%,n=2)。1 例患者需要静脉动脉体外膜肺氧合。死亡率为 25%(n=9)。62.9%(n=22)的患者检测到急性心肌损伤和 N 末端 pro-B 型利钠肽(NT-proBNP)升高。与存活出院的患者相比,死亡患者的 NT-proBNP 更高(p<0.05)。心脏病专家的护理经常改变决策。

结论

COVID-19 的心血管影响似乎很重要,但仍知之甚少。需要研究来阐明心脏标志物在 COVID-19 预后中的作用。多学科护理很可能会改善患者的护理。